Novo Nordisk (NVO) PT Raised to $55 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Evan Seigerman raised the price target on Novo Nordisk (NYSE: NVO) to $55.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
